iBio
IBIO
IBIO
53 hedge funds and large institutions have $7.63M invested in iBio in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less capital invested
Capital invested by funds: $17.5M → $7.63M (-$9.87M)
59% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 27
Holders
53
Holding in Top 10
–
Calls
$154K
Puts
$121K
Top Buyers
| 1 | +$1.22M | |
| 2 | +$480K | |
| 3 | +$272K | |
| 4 |
Renaissance Technologies
New York
|
+$189K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$131K |
Top Sellers
| 1 | -$2.97M | |
| 2 | -$982K | |
| 3 | -$417K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$373K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$360K |